Lundbeck
HLUN-B.CO
#2442
Rank
NZ$10.34 B
Marketcap
$10.84
Share price
0.62%
Change (1 day)
34.86%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - P/B ratio

P/B ratio as of November 2024 : 1.80

According to Lundbeck 's latest financial reports the company has a price-to-book ratio of 2.01641.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Lundbeck - P/B ratio (from 2009 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-311.4419.29%
2022-12-311.21389.39%
2021-12-310.2468-24.87%
2020-12-310.3285-18.51%
2019-12-310.4031-24.37%
2018-12-310.5330-22.52%
2017-12-310.6880-12.94%
2016-12-310.790211.56%
2015-12-310.7083195.88%
2014-12-310.2394-10.42%
2013-12-310.267361.86%
2012-12-310.1651
2011-12-31N/A-100%
2010-12-310.2504-13.54%
2009-12-310.2896